Hitler Speech Essay Example for Free

Hitler Speech Essay Adolph Hitler is known by his charismatic personality, his strict military background, and his expressive and formal attitude in giving speeches. Hitler’s speech given on the 26th of September 1938, among all the millions of words that he addressed to his audience, is the most enthusiastic, optimistic, and motivated speeches I’ve read. Hitler started off his speech insisting to solve the problem he has in Europe, he showed that he is persistent, determined and eager to do so. Withdrawing and not resolving the issue was not one of his options, he was strong minded to get to the bottom of it. Hitler believed that, with the faith of God, he will succeed. Hitler used unusual words when addressing specific people and countries. Him using terms such as ‘crazy so-called’, illustrates that he was doubtful and alleged that these statesmen of Europe were not even qualified enough for their positions. Moreover, he also labeled the new states they formed as â€Å"so called states†; Hitler didn’t even identify them as real states. So-called is type of slogan used to falsely think of something. Europe thought it had skilled and entitled statesmen whom formed new states, but to Hitler; they were anything but eligible statesmen whom formed anything but upright states. Hitler, later in his speech, mentioned a person named Mr. Benes; he introduced him as â€Å"This Mr. Benes†. For Adolph Hitler to use such expressions, that proved that he pitted him, and didn’t consider him as respectful human. Hitler knew all his lies. While giving his speech he was sending a message showing that he wasn’t fooled nor tricked. Part of the speech that grabbed my attention personally was â€Å"Now the shameless part†¦.. t their own brothers† because of 2 reasons. He described the policies that were implemented by the government as terrible policies, but he didn’t mention any specific word stating that, instead by saying â€Å"policy which†¦. shoot at their own brothers† it perfectly showed exactly what kind of policies they were, policies so dreadful to fact it will turn them against each other and start a civil war. Hitler compared himself with Mr. Benes mentioning himself as decent solider, but Benes; as a sneaky man, who did not play by rules. He proclaims that he will stand against him and declare war if he has too, and he will stand by his people and protect them by saying he is their soldier. Hitler demonstrated himself as a patient man, he dealt with Benes in a sophisticated way. Hitler was so determined in gaining Germany their freedom, one way or another. Hitler was threating Mr. Benes. He showed it by giving him an offer, if he didn’t accept it, Hitler would start a war. This indorsed his strength and power, he never took no for answer. If Hitler wants something he fights for it. What made Hitler make such threats is because Mr. Benes made him wait for so long, and it exceeded his patience. Another thing I liked personally in Adolph Hitler’s speech is when he talks about himself and his public, he makes it sound as if they are all equal, and they stand side by side, all of them together. He didn’t make them feel he was a leader and that they had to follow and obey him. Hitler ended his speech with convincing his public, all the German people both men and women to fight with him, stand with him by his side against Mr.  Benes. He motivated the public and encouraged them; moreover he was building confidence in them when saying they are stronger than before. Hitler also gave them an example of himself when he was an ordinary soldier, commenting that he didn’t have doubts of succeeding, and having faith in victory. I think we was trying to point out to the public that, even though you are just a normal individual (just like himself back then), it won’t prevent you from conquering your enemy. To come to a conclusion, from my point of view, I see this speech as a motivational speech to the public to fight against whoever isn’t fair with them. It was also a kind of threat to Mr. Benes, threating him to make his decision faster or else, Hitler will start a war against him. Hitler dealt with his issue patiently, even though his patience came to an end, he didn’t attack his enemy aggressively; He simply warned him. Generally speaking, Hitler was a worldly wise man, a supreme leader, and role model to many.

Naked Essay -- essays research papers

Naked David Sedaris; Little Brown & co. 1997 â€Å" The women’s open† 1. Throughout the essay â€Å" The women’s open† David’s father obsession for golf is shown. The power of his obsession leads him to forget what should be important to him. 2. Sedaris expresses the lack of heart his father shows towards people and even his children when it comes down to golf. For example the first day Lisa ever got her period was out on the golf course while her dad was watching a professional tournament, at first while she complained about her back pains he just simply brushed her off. At the moment he realized the problem he asked a women just as devoted to golf as he to accompany her to the ladies room for a sanitary napkin. He kept David with him so he could run after the thin tees that usually flew 20 feet away from the golfers swing, just so he could keep them for good luck. On another occasion Lisa’s mother had recorded a video of movies that they enjoy watching together. After her mother had passed away Lisa searched everywhere for the video her mother had made for her. She found it in her fathers basement along with all his golf videos. As she began to watch the video memories began to arise until a man bending down on a golf course appeared on the screen. Her father had recorded a golf tournament over her mothers memories. Sedaris succeeded in letting the reader know how obsessed his father was with golf and the pain it put the family through. 3. Sedaris begins with a short passage foreshadowing an event that will occur that day. He begins this way to let the reader know that there is importance behind the story. After his foreshadowing he commences with the story. 4. Sedaris uses descriptive sets of paragraphs followed by dialogue to express what is going on. For example, returning from the tournament they find Lisa lying in the back seat of his Porsche. the first word out of Lisa’s mouth were not too pleasant . â€Å" My father sighed and shook his head in disappointment. This was the same way he reacted to my mother when anger and frustration caused her to forget herself. Lisa was not a daughter now but just another female unable to control her wildly shifting emotions. â€Å" Don’t mind her,† he said wiping a thin coat of pollen of the wind shield. â€Å" She’s just having lady problems.† † 5. I think Sedaris was very effective in his writing. I don’t like g... ...fe to what I believe he wished it was. But when it comes down it, his family has as many money problems as an average family. 3. Beginning his first line of his first essay in his book with a command he would like to give one of his servants is misleading. Sedaris structures his essay in a way that makes the reader believe that he is rich. But he expresses how he was far from being rich. 4. Sedaris language is beyond effective, his sentences are full of considedness and snobby comments. â€Å"When asked most people say my greatest asset is my skin, which glows it really does! I have to tie a sock over my eyes in order to sleep at night. Other’s like my eyes or my perfect ,gleaming teeth my thick head of hair or my imposing stature, but if you want my opinion, I think my most outstanding feature is my ability to accept a compliment.† His conclusion to the story makes up for all the nonsense he had mentioned before. 5. I thought Sedaris’s first essay â€Å"chipped beef† was a hilarious arrangement of considedness and make believe. Although this essay is not arranged with the perverted humor featured in some of his other essays, he had a very effective way in making the readers laugh

Professional Communication Essay

The reasoning behind ISO 9000 certification in manufacturing is to ensure uniformity in processes as an assurance of levels of quality. By creating sets of standards to which the manufacturing process must adhere, only acceptable product is released for shipment or sale. With the development of and subsequent compliance with ISO-9000 standards in mind, it is critical to construct a realistic and effective ISO standard. The cornerstone of this construction is the charter documentation. Just as the ISO standard itself is used as a quality control measure, the charter is a control method for the formulation of the standard itself. Basically, ISO in manufacturing is intended to cover two major areas- people and processes. Without giving personnel the proper training to carry out the standard, the processes will not be reflective of the quality standards brought forth by ISO. For these reasons, charters must be carefully developed in a multi-faceted approach. Charters are typically most effective when driven from the managerial/supervisory level from the beginning. In regard to this managerial input in the chartering process, management should detail their responsibility in the ISO program. This will achieve two very important things- it will be a reasonable assurance that the charter reflects the overall initiatives of the organization as envisioned by management and will show the subsequent lower levels of company hierarchy that this is something that management is taking a part in and not merely issuing a mandate without leadership by example. Just as management has to have a level of responsibility in the charter, the individuals who are involved in more of the hands-on aspects of production need to make a contribution to the charter. The insight that production personnel will be able to provide in the creation of a useful charter is vast. These individuals have seen the best and worst of the actual manufacturing that goes on daily; as such, best practices can be incorporated into the charter from the start. Design control must also have a place in the charter document; from the outset, of course the charter will correspond to existing product; in the case of new product development as an example, designs must fall under the same requirements as does a long-standing product. The same would apply to modifications of existing product. Document and data control are essential elements of the charter; being able to achieve uniformity and quality in the ways that work orders, shipping documentation, product specifications and purchase orders are created and processed will aid in the carry through of quality standards beyond the shop floor and into the administrative and clerical areas of the manufacturing facility. Up to this point, the charter has been considered in terms of how it will correspond to things being done correctly. Just as important is the consideration of what will be done when inevitable errors and problems arise. For these occurrences the proper planning and execution of corrective actions, as well as follow up to assure that the original error does not become a repeat event, can be incorporated into the charter. In this case, malfunctions are accounted for in addition to best practices. After the charter’s collaborators, scope and purpose is in place, the launch of the charter comes into play. The document itself begins with a clearly stated purpose which can literally be understood by those of technical and non-technical backgrounds alike. Not only can the words be understood in terms of what they explicitly say, but also easily lend themselves to adaptability on the part of the audience; in other words, the words can be processed in the mind of the audience and they can then begin the thought process of exactly what the Charter will ultimately mean to their job tasks, and most likely open up a dialogue among the audience members in regard to how they will all collaborate, with the Charter as a framework, for the achievement of quality objectives as required. If looking at nothing else but the intended use and audience of the Charter, the strengths are many. In fairness, however, some weaknesses likewise exist. Audience is perhaps the most important consideration in the production of any technical document, and especially in the case of the ISO Charter, not only because of the fact that this document, by its nature of being a quality control document should set an example for quality and would discredit the ISO process if it was not of the highest quality, but also because of the fact that the Charter is intended to be used by a huge variety of manufacturers, quite literally around the world. Because of these audience factors, the Charter often is interpreted not only according the particular industry that it will be dictating to, but also translated into different languages for different nations, and comprehension levels; for example, an automobile manufacturer in France will be using the same base document, in the form of the ISO Charter, as would a paper mill in Mexico- different industries, different cultures, and possibly even different educational levels and therefore levels of reading comprehension. Because of this, the demographic element of the audience for this particular document deserves additional discussion. The ISO Charter, by necessity and purpose, has to possess a sort of universal quality in terms of its intended audience; as was previously mentioned, the document will at any given time be used by any given industry in any given part of the world, creating operational and cultural variations that must be taken into account. Further, even within one organization itself, the Charter will have to be flexible in its target audience, which is better understood with a brief description of how an ISO Charter may be utilized at varying authority levels in the same operation. Initially, the Charter would be reviewed by the upper management, possibly delegated to middle management, and ultimately to the rank and file. This being understood, it is also important to understand that everyone must be able to interpret it and adapt what it teaches for their own uses if it is to achieve the ultimate goals that led to the adaptation of the Charter in the first place. The close relationship between the charter and the subsequent ISO standards that will branch out from it are much like blueprints from which a finished product emerges. Because the charter has multi-level participation, precise details of how all areas of the manufacturing facility will be involved in the end goal of quality in line with ISO, and controls in place in the event of errors or problems, the charter possesses the unique ability to literally instill quality in the ISO standard itself. While the viewpoint of some manufacturers is that ISO is best used as an effective means to gain competitive advantage merely by the existence of the ISO logo on finished products, the true intention of correctly used ISO standards- continuous improvement, an assured level of quality, and the means to fix whatever may jeopardize that standard of quality- seems to be more palatable to the majority of manufacturers. This is especially so given the dynamic nature of the competition in some industries. Guided by an efficient charter, the ISO standard can be properly formulated and enacted over the long term in pursuit of quality objectives.

Stem Cell Therapy - Free Essay Example

Sample details Pages: 9 Words: 2697 Downloads: 6 Date added: 2019/06/26 Category Biology Essay Level High school Tags: Stem Cell Essay Did you like this example? The heart is one of the most essential organs in the human body. It is what keeps almost every organism alive. However, recent studies have found that heart disease is the leading cause of death in America, creating a problem for the medical communities that are trying to save lives. Don’t waste time! Our writers will create an original "Stem Cell Therapy" essay for you Create order Not only is it nearly impossible for doctors to cure a damaged heart for a long term, it is also costly and leads to more surgeries just to keep the patient alive for a couple more weeks. The answer to this then comes in with heart transplants. But with more people dying of heart disease on the transplant list than there are of actual hearts able to be transplanted, there is still a problem when it comes to finding the solution to Americas number one cause of death. Scientists have recently started the practice of tissue engineering for skin replacement. This involves taking the patients own stem cells and growing them outside of the body for the replacement therapy. This practice is called regenerative medicine and scientists are searching for more ways to take existing stem cells and create new tissue that will heal organs like the heart. Recent practices for organ regeneration, especially for the heart, include grafting stem cells to the dying heart of a patient, bone marrow stem cell therapy, and many others. However, there is still no procedure that can be labeled as the most effective for improved cardiac function because there are too many different types of stem cells being altered during pre-clinical studies. These pre-clinical studies using tissue engineered grafts for cardiovascular disease treatment are taking place all over the world, but scientists still have not been able to take their findings to large clinical trials because of unknown knowledge regarding the procedure itself. Instead doctors will do small clinical trials with patients who consent to undergo a type of the cardiac stem cell procedure because the doctors are still unsure of the effects and the results of the procedure yield minimal improvement. However, in most instances patients usually end up with either neutral or insignificant positive results because doctors do not understand what factors play into healing an infarcted heart (Gersh). Even though conducting large scale clinical trials would solve the problem of the heart donor organ shortage for Americans, there are still many problems that arise when it comes to stem cells and heart regeneration in humans, including the cardiac improvement when small clinical trials and pre-clinical trials are taking place. Therefore, stem cell therapy for cardiac regeneration in humans should not be taking place in large scale clinical trials until consistent results in hearts are found from pre-clinical or small clinical trials. This would allow scientists to identify, to the best of their ability, what is happening when the stem cells are grafted, instead of continuing trials blindly. The most generalized reason why stem cell therapy for cardiac regeneration should not be happening in clinical trials is because the results are inconsistent, so they are taking a risk every time a small clinical trial on a human is done. Dr. Gersh from Mayo Clinic reports that almost all small clinical trials in humans for heart regeneration have been found as positive or neutral, but with insignificant positive results. Therefore, large scale clinical trials on humans should cease because they are not technically helping patients in the long run and could pose a risk on future trials because the current results have been inconsistent since the trials have been taking place. A study in the American Heart Journal reported that stem cell therapy trials in myocardial infarction using a specific stimulating factor (G-CFS) also had inconsistent results. If so many pre-clinical and small human clinical trials are showing inconsistent results in regards to heart function, then doctors sho uld not be performing large scale clinical trials with thousands of people. There is potential harm to be done to thousands of patients heart if doctors use their unknown knowledge from small clinical and pre-clinical trials to perform large scale clinical trials. Also, if scientists and doctors cannot identify to the best of their ability what is happening within the body when the cells are grafted to the heart, they do not know what the possible side effects may be. Along with the study in the American Heart Journal there was a 2 year follow up of the different strategies of the G-CFS based stem cell therapy (Hyun-Jae Kang). This study reported little improvement over other types of therapy and even the control group. Even though it did show minimal improvement over 2 years, this could be detrimental to the patient because even though his heart has been fixed, there might be longer term side effects which have not been recorded. This is a problem as well because most of the studies are so recent that there have not been patients that have undergone this therapy that would give scientists information about side effects that may occur five to ten years down the line. However, many drugs and therapies that were skeptical at their time of debut are in fact perfectly fine now. Dr. Gersh from Mayo Clinic relates cardiac regeneration using stem cell therapy to the effects of aspirin. Although the underlying understanding of how the drug worked was not understood at the time, scientists have finally been able to recognize what the drug actually does in the past ten or so years. This makes a credible case for continuation of cardiac regeneration using stem cell therapy because maybe, in ten years after successful surgeries using stem cell therapy on the heart, doctors will finally be able to understand what the cells are doing. Although, in the meantime, even though some of the findings of this therapy are positive or neutral, there is still that unknown underlying reason of why the cells are acting the way they are, and trials should not be continued because of this sole reason. In most cases, almost all of the infarcted hearts of rats and mice have shown improvement after stem cell therapy, creating excitement among the medical community (Chien). But if scientists cannot identify what is going on within the heart during the therapy, they should not be continuing it because it poses a risk for patients undergoing the procedure. It could work minimally, or it could not work at all. Scientists should take a step back and try to understand why the cells do what they are doing before they place them into patients hearts through small clinical trials on groups of patients instead of going directly to large scale clinical trials. Or scientists and could take a step further back and do pre-clinical trials on mamm als more closely related to humans in regards to heart function and characteristics in order to more fully understand what the stem cells are doing. Scientists are also trying to force something biologically unnatural onto mammals, brining in more risks for the patients. Sicasts published an article titled Scientists Discover a Key to a Broken Heart which talks about regenerative properties in the zebrafish and how researchers are studying the way the zebrafish regenerate and take it to mammalian trials. A quote from the article states, However, despite our current understanding of how embryogenesis and development proceeds, the mechanisms preventing regeneration in adult mammals have remained elusive (4). The researchers have been trying to understand what exactly prevents regeneration in mammals, but even with their understanding of the zebrafish, they cannot identify what is blocking adult mammals to regenerate organs. This shows to help exemplify that even with all the knowledge these researchers have, they are still unable to determine if mammals can even regenerate and if they cannot understand why adult mammals cannot rege nerate, then they should not be trying to force it in clinical procedures for the heart. Unlike the salamander and other fish species, humans and other mammals are not biologically programmed to regenerate organs when they are failing. So the questions remain: Is it right for science to push something onto people that could possibly save their lives, but be unnatural for their body to perform? Yet, scientists have not deemed the process to be unnatural to the human body because they are taking the persons own stem cells to recreate the cells to fix the heart. Technically they are not putting anything foreign into the patients body, but they are still changing the genetic makeup of the cells to create something that could not have been created without humankind. So the question still remains if it is morally right or wrong to change the genetic makeup of a humans cells to repair the body when it could not be repaired before the advancement of medicine and technology. Even if this stem cell therapy for cardiac regeneration does in fact help save lives, it is merely unnatural for human cells to regenerate, so, again, the unknown consequences pose another risk. By replicating cells and programming them to behave a certain way scientists are almost acting as a creator. This act leaves moral stipulations behind and urges humans to reprogram what creates their body in order to heal it. Medicine has come so far, yet it is still not right for scientists to be able to reprogram cells in order to heal if the consequences are not known and if the body was not meant to heal that way in the first place because it could cause damage to the body. By doing something biologically unnatural to the cells in a human body, scientists are somewhat playing with fire because they do not know the consequences of their experiments. It could be that by reprogramming cells in humans scientists are creating something they cannot control because they do not know what is causi ng the change in the heart. By doing large scale clinical trials, scientists and doctors are risking creating something they cannot undo. Scientists need to study these cells in small clinical trials and pre-clinical experiments in order to fully understand them before they take them to large trials. Another reason why cardiac regeneration using stem cell therapy should not be taking place in large scale clinical trials and poses a risk, is the lack of pre-clinical trials on hearts closely related to human hearts, creating inconsistent statistics that should not be used as a basis for large clinical trials on humans. Most of the pre-clinical trials done on cardiac regeneration have taken place in mice, whose hearts are significantly different than those of humans. Much of our insight into the molecular and cellular basis of cardiovascular biology comes from small animal models, particularly mice. However, significant differences exist with regard to several cardiac characteristics when mice are compared with humans (Gandolfi 5). Much of the results that have yielded positive improvement in grafted stem cells into the heart have been from pre-clinical studies using mice. Scientists should also not use this information to base small clinical trials on. In order for scientists to ta ke their findings to large clinical trials they need to take a step back through pre-clinical and small clinical trials once they find consistent results in small clinical trials. This idea of taking information found from mice hearts to human hearts poses a risk for large scale human clinical trials because the difference between mice hearts and human hearts is quit significant as shown in the table below from the journal article Large animal models for cardiac stem cell therapies. Scientists should take their pre-clinical trials from mice to a larger animal with a heart that is more closely related to a humans heart so the results are more consistent with what a the results of a human heart would possibly be. By basing what route to take in clinical trials on pre-clinical trials on mice, scientists are taking a risk in regards to the outcome of the procedure on human hearts because of the difference of physical characteristics in both hearts. However, this is not a problem for pre-clinical studies because it does provide reliable information on how hearts work and act after stem cell therapy grafting, but transferring that knowledge from a mouse heart to a human heart is not reliable because of the significant difference between mice and human hearts. Scientists should continue to study mice hearts and the effects of stem cell grafting because it does provide relevant information for future studies, but they should not relate those findings to human hearts because of how different they are. Instead, the scientists should relate information found from mice hearts to hearts of mammals that are slightly larger and work their way up until they find suitable mammal hearts to relate to human hearts. Doctors should then take their findings from these pre-clinical studies and relate them to small clinical trials with little groups of people, but only until the pre-clinical studies have shown consistent results in hearts closely r elated to humans. With tissue engineering and the idea of regeneration becoming more prominent in the medical community, there are many possibilities as to what could come of cardiac regeneration in humans. The possibilities are endless when scientists are able to reprogram patients own cells to create something different. However, the unknown still poses a risk and problem for doctors and patients when these procedures using stem cells are involved. Especially when the heart is involved as the main organ being treated. Although most findings are neutral or slightly positive when cardiac regeneration using stem cells is done, the underlying problem is that there is still inconsistent results and scientists are moving too fast for their research. Instead of trying to take findings from pre-clinical studies that involve mice and rats to large clinical trials, scientists need to take a step back and understand what is going on within the cells and use hearts in mammals that can clearly relate to human hearts. Once those factors yield consistent results in heart function, scientists can take their studies to small clinical trials. But scientists should only start doing large scale clinical trials once the findings in pre-clinical and small clinical trials are consistent. There needs to be more order in the process for doctors and scientists to take their findings to large clinical trials involving hundreds of people. Once results in pre-clinical using mammal hearts related to humans are consistent and promising, scientists can move onto small clinical trials involving little groups of patients. Then, if the results among small clinical trials with human hearts are positive and show a larger improvement than previously recorded, doctors will be able to take their findings to large clinical trials that will finally impact more humans with heart disease in America. This is going to be a long process, especially now that scientists should back track and go to pre-clinical trials, but it will be more beneficial for the patients and humanity if scientists and doctors can fully understand stem cells before they create something that could pose a risk to human health. Works Cited Anonymous.Heart Disease Facts. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 29 Oct. 2014. Web. 7 Dec. 2014. . Anonymous. NIH Fact Sheets Regenerative Medicine. NIH Fact Sheets Regenerative Medi cine. U.S. Department of Health Human Services, 1 Oct. 2010. Web. 7 Dec. 2014. . Anonymous. Scientists Discover a Key to Mending Broken Hearts. Scicasts. N.p., 07 Nov. 2014. Web. 08 Nov. 2014. . Chien, Kenneth R. Stem Cells: Lost In Translation. Nature (2004): 607-08. Nature.com. Web. 5 Nov. 2014. . Gandolfi, F., A. Vanelli, G. Pennarossa, M. Rahaman, F. Acocella, and T.a.l. Brevini. Large Animal Models for Cardiac Stem Cell Therapies. Theriogenology 75.8 (2011): 1416-425. Web. 6 Nov. 2014. . Gersh, Dr. Bernard J. Cardiac Cell Repair Therapy: A Clinical Perspective. Interview. Mayo Clinic. N.p., Oct. 2009. Web. 7 Nov. 2014. . Hyun-Jae Kang, Hyo-Soo Kim, Bon-Kwon Koo, Yong-Jin Kim, DongSoo Lee, Dae-Won Sohn, Byung-Hee Oh, Young-Bae Park. Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-Year follow-up results of the Myocardial Regenera- tion and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion. American Heart Journal. Volume 153. Issue 2. Feb. 2007. Pages 237.e1-237.e8. Web. 27 Nov. 2014. .